GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Total Current Assets

Voyageur Pharmaceuticals (TSXV:VM) Total Current Assets : C$0.45 Mil (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Voyageur Pharmaceuticals's total current assets for the quarter that ended in Feb. 2024 was C$0.45 Mil.


Voyageur Pharmaceuticals Total Current Assets Historical Data

The historical data trend for Voyageur Pharmaceuticals's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Total Current Assets Chart

Voyageur Pharmaceuticals Annual Data
Trend Dec14 Dec15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.03 0.89 0.16 0.09

Voyageur Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.22 0.10 0.09 0.45

Voyageur Pharmaceuticals Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Voyageur Pharmaceuticals's Total Current Assets for the fiscal year that ended in Nov. 2023 is calculated as

Voyageur Pharmaceuticals's Total Current Assets for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Voyageur Pharmaceuticals  (TSXV:VM) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Voyageur Pharmaceuticals's Liquidation Value for the quarter that ended in Feb. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.25-0.985+0.75 * 0.018+0.5 * 0.01
=-0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Voyageur Pharmaceuticals Total Current Assets Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Voyageur Pharmaceuticals (TSXV:VM) Business Description

Traded in Other Exchanges
Address
333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1
Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.
Executives
Charles Littlejohn 10% Security Holder

Voyageur Pharmaceuticals (TSXV:VM) Headlines

No Headlines